Cover Image
市場調查報告書

生物科技的全球市場分析:用途,各技術

Biotechnology Market Analysis By Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing Bioinformatics), By Technology, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 557221
出版日期 內容資訊 英文 149 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生物科技的全球市場分析:用途,各技術 Biotechnology Market Analysis By Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing Bioinformatics), By Technology, And Segment Forecasts, 2014 - 2025
出版日期: 2017年08月17日 內容資訊: 英文 149 Pages
簡介

本報告提供全球生物科技市場相關調查,彙整市場趨勢與各用途,各技術,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場變動,趨勢,範圍

  • 市場區隔和範圍
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 滲透及成長預測製圖
  • 企業市場佔有率分析
  • SWOT分析
  • 波特的五力分析

第4章 各用途市場

  • 趨勢分析
  • 醫療
  • 食品·農業
  • 天然資源·環境
  • 產業加工
  • 生物資訊學
  • 其他

第5章 各技術市場

  • 趨勢分析
  • 奈米生物科技
  • 組織工程及再生
  • DNA定序
  • 細胞化驗分析
  • 發酵
  • PCR技術
  • 層析法
  • 其他技術

第6章 各地區市場

  • 市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • 策略架構
  • 企業簡介
目錄
Product Code: 978-1-68038-134-4

The global biotechnology market is expected to reach USD 727.1 billion by 2025, according to a new report by Grand View Research, Inc. The emergence of certain key themes in the biotechnology market is expected to drive growth in this industry to a lucrative extent.

These key themes include regenerative medicine and genetics in diagnostics. Presence of a plethora of companies focusing on the development of regenerative therapies is anticipated to drive sector growth through to 2025. Technological advancements pertaining to the penetration of artificial intelligence in this industry is expected to fuel progress with potential avenues. The companies are engaged in unleashing machine learning in order to understand individual cancer cases, while recommending clinical trials.

Supportive government (and its allied agencies) policies related to synthetic biology is a major growth impacting driver in this sector. Developed economies such as UK and the U.S. are critically monitoring and funding synthetic biology R&D initiatives. For example, in 2010, a six months' review of synthetic biology headed by a panel of expert scientists was enforced by the U.S. President and subsequently conducted a hearing of the Energy and Commerce Committee exclusively concerning synthetic biology.

Further key findings from the report suggest:

  • Owing to technological advancements and widespread application of this field in various aspects of healthcare, the health segment is expected to exhibit strong progress in the forecast period
  • Continuous introduction of new biotechnological products to cater to healthcare entities that are involved in diagnosis, prognosis and biopharmaceutical development is estimated to propel the market
  • Decreasing costs and rise in number of services in this segment are expected to drive segment with lucrative avenues
  • North American pharmaceutical and biotech companies have experienced great success in the recent years resulting in larger share
  • Introduction of technologically advanced products and presence of various biotechnology based programs such as the UC Davis Biotechnology Program, the University of California Biotechnology Research and Education Program are attributive to drive the growth of sector in the coming years
  • Asia Pacific market is anticipated to grow at the most lucrative pace due to changing health care infrastructure in this region which drives the demand for these products
  • Strong governmental support and recruitment of highly trained Chinese scientists with the support of their administration has made it possible for China to speedily build up capacity in area of regenerative medicine

Key players operating include Gilead, Celgene, Abbott, Novo Nordisk A/S,Novartis AG, Sanofi Aventis, and Lonza

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
    • 1.1.1 Purchased Database
    • 1.1.2 GVR's Internal Database
  • 1.2 Data Analysis
  • 1.3 Market Formulation & Validation
  • 1.4 Approaches for Market Estimation
    • 1.4.1 Approach 1: Commodity Flow & Bottom Up Approach
    • 1.4.2 Approach 2: Top Down and Parent Market Analysis

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Biotechnology Market: Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Presence of favorable government initiatives
      • 3.1.1.2 Rising demand for agro-based products
      • 3.1.1.3 Growing demand for synthetic biology
      • 3.1.1.4 Declining prices of DNA sequencing
      • 3.1.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Ethical issues related with clinical trials
      • 3.1.2.2 Risks associated with GM organisms and crops
      • 3.1.2.3 Challenges associated with NGS implementation
  • 3.2 Penetration & Growth Prospect Mapping for Technology, 2016
  • 3.3 Company market share analysis
  • 3.4 Biotechnology Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Industry Analysis - Porter's

Chapter 4 Biotechnology Market: Application Estimates & Trend Analysis

  • 4.1 Biotechnology Market: Application Movement Analysis
  • 4.2 Health
    • 4.2.1 Global health biotechnology market, 2014 - 2025 (USD Billion)
  • 4.3 Food & Agriculture
    • 4.3.1 Global agriculture biotechnology market, 2014 - 2025 (USD Billion)
  • 4.4 Natural resources & environment
    • 4.4.1 Global natural resources & environment market, 2014 - 2025 (USD Billion)
  • 4.5 Industrial Processing
    • 4.5.1 Global industrial processing market, 2014 - 2025 (USD Billion)
  • 4.6 Bioinformatics
    • 4.6.1 Global bioinformatics market, 2014 - 2025 (USD Billion)
  • 4.7 Other Applications
    • 4.7.1 Global other applications market, 2014 - 2025 (USD Billion)

Chapter 5 Biotechnology Market: Technology Estimates & Trend Analysis

  • 5.1 Biotechnology Market: Technology Movement Analysis
  • 5.2 Nanobiotechnology
    • 5.2.1 Global nanobiotechnology market, 2014 - 2025 (USD Billion)
  • 5.3 Tissue engineering and regeneration
    • 5.3.1 Global tissue engineering and regeneration market, 2014 - 2025 (USD Billion)
  • 5.4 DNA Sequencing
    • 5.4.1 Global DNA sequencing market, 2014 - 2025 (USD Billion)
  • 5.5 Cell-based Assays
    • 5.5.1 Global cell based assays market, 2014 - 2025 (USD Billion)
  • 5.6 Fermentation
    • 5.6.1 Global fermentation market, 2014 - 2025 (USD Billion)
  • 5.7 PCR technology
    • 5.7.1 Global PCR technology market, 2014 - 2025 (USD Billion)
  • 5.8 Chromatography
    • 5.8.1 Global chromatography instruments market, 2014 - 2025 (USD Billion)
  • 5.9 Other Technologies
    • 5.9.1 Global other technologies market, 2014 - 2025 (USD Billion)

Chapter 6 Biotechnology Market: Regional Estimates & Trend Analysis, by Application & Technology

  • 6.1 Biotechnology Market Share by Region, 2016 & 2025
  • 6.2 North America
    • 6.2.1 North America biotechnology market, 2014 - 2025 (USD Billion)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. biotechnology market, by application, 2014 - 2025 (USD Billion)
      • 6.2.2.2 U.S. biotechnology market, by technology, 2014 - 2025 (USD Billion)
    • 6.2.3 Canada
      • 6.2.3.1 Canada biotechnology market, by application, 2014 - 2025 (USD Billion)
      • 6.2.3.2 Canada biotechnology market, by technology, 2014 - 2025 (USD Billion)
  • 6.3 Europe
    • 6.3.1 Europe biotechnology market, 2014 - 2025 (USD Billion)
    • 6.3.2 Germany
      • 6.3.2.1 Germany biotechnology market, by application, 2014 - 2025 (USD Billion)
      • 6.3.2.2 Germany biotechnology market, by technology, 2014 - 2025 (USD Billion)
    • 6.3.3 UK
      • 6.3.3.1 UK biotechnology market, by application, 2014 - 2025 (USD Billion)
      • 6.3.3.2 UK biotechnology market, by technology, 2014 - 2025 (USD Billion)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific biotechnology market, 2014 - 2025 (USD Billion)
    • 6.4.2 Japan
      • 6.4.2.1 Japan biotechnology market, by application, 2014 - 2025 (USD Billion)
      • 6.4.2.2 Japan biotechnology market, by technology, 2014 - 2025 (USD Billion)
    • 6.4.3 China
      • 6.4.3.1 China biotechnology market, by application, 2014 - 2025 (USD Billion)
      • 6.4.3.2 China biotechnology market, by technology, 2014 - 2025 (USD Billion)
  • 6.5 Latin America
    • 6.5.1 Latin America biotechnology market, 2014 - 2025 (USD Billion)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil biotechnology market, by application, 2014 - 2025 (USD Billion)
      • 6.5.2.2 Brazil biotechnology market, by technology, 2014 - 2025 (USD Billion)
  • 6.6 Middle East & Africa
    • 6.6.1 Middle East & Africa biotechnology market, 2014 - 2025 (USD Billion)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa biotechnology market, by application, 2014 - 2025 (USD Billion)
      • 6.6.2.2 South Africa biotechnology market, by technology, 2014 - 2025 (USD Billion)

Chapter 7 Competitive Landscape

  • 7.1 Market participation categorization
  • 7.2 Company Profiles
  • 7.3 AstraZeneca
    • 7.3.1 Company overview
    • 7.3.2 Financial performance
    • 7.3.3 Product benchmarking
    • 7.3.4 Strategic initiatives
  • 7.4 Gilead
    • 7.4.1 Company overview
    • 7.4.2 Financial performance
    • 7.4.3 Product benchmarking
    • 7.4.4 Strategic initiatives
  • 7.5 CELGENE CORPORATION
    • 7.5.1 Company overview
    • 7.5.2 Financial performance
    • 7.5.3 Product benchmarking
    • 7.5.4 Strategic initiatives
  • 7.6 Biogen
    • 7.6.1 Company overview
    • 7.6.2 Financial performance
    • 7.6.3 Product benchmarking
    • 7.6.4 Strategic initiatives
  • 7.7 Abbott
    • 7.7.1 Company overview
    • 7.7.2 Financial performance
    • 7.7.3 Product benchmarking
    • 7.7.4 Strategic initiatives
  • 7.8 Amgen, Inc.
    • 7.8.1 Company overview
    • 7.8.2 Financial performance
    • 7.8.3 Product benchmarking
    • 7.8.4 Strategic initiatives
  • 7.9 Novo Nordisk A/S
    • 7.9.1 Company overview
    • 7.9.2 Financial performance
    • 7.9.3 Product benchmarking
    • 7.9.4 Strategic initiatives
  • 7.10 Merck & Co
    • 7.10.1 Company overview
    • 7.10.2 Financial performance
    • 7.10.3 Product benchmarking
    • 7.10.4 Strategic initiatives
  • 7.11 Johnson & Johnson Services, Inc.
    • 7.11.1 Company overview
    • 7.11.2 Financial performance
    • 7.11.3 Product benchmarking
    • 7.11.4 Strategic initiatives
  • 7.12 Novartis AG
    • 7.12.1 Company overview
    • 7.12.2 Financial performance
    • 7.12.3 Product benchmarking
    • 7.12.4 Strategic initiatives
  • 7.13 Sanofi Aventis
    • 7.13.1 Company overview
      • 7.13.1.1 Genzyme
    • 7.13.2 Financial performance
    • 7.13.3 Product benchmarking
    • 7.13.4 Strategic initiatives
  • 7.14 F. Hoffmann-La Roche Ltd
    • 7.14.1 Company overview
    • 7.14.2 Financial performance
    • 7.14.3 Product benchmarking
    • 7.14.4 Strategic initiatives
  • 7.15 Pfizer, Inc.
    • 7.15.1 Company overview
    • 7.15.2 Financial performance
    • 7.15.3 Product benchmarking
    • 7.15.4 Strategic initiatives
  • 7.16 Lonza
    • 7.16.1 Company overview
    • 7.16.2 Financial performance
    • 7.16.3 Product benchmarking
    • 7.16.4 Strategic initiatives

List of Tables

  • TABLE 1 Healthcare expenditure levels, 2012
  • TABLE 2 Various approaches in regenerative medicine for dermatological use
  • TABLE 3 North America: Clinical studies using HCT for hematopoietic and non-hematopoietic conditions (2016)
  • TABLE 4 North America biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 5 North America biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 6 U.S. biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 7 U.S. biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 8 Canada biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 9 Canada biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 10 Europe biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 11 Europe biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 12 Germany biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 13 Germany biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 14 UK biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 15 UK biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 16 Asia Pacific biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 17 Asia Pacific biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 18 Japan biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 19 Japan biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 20 Main monographs published in china
  • TABLE 21 China biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 22 China biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 23 Latin America: Current initiatives and opportunities
  • TABLE 24 Latin America biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 25 Latin America biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 26 Brazil biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 27 Brazil biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 28 MEA biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 29 MEA biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)
  • TABLE 30 South Africa biotechnology market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 31 South Africa biotechnology market estimates & forecasts, by technology, 2014 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market snapshot
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Global area of biotech seeds, 2007 - 2012 (million acres)
  • FIG. 12 Revenues from GM and conventional seeds, 2007 - 2011 (USD Billion)
  • FIG. 13 Genome sequencing cost, 2002 - 2013 (USD thousands)
  • FIG. 14 Market restraint relevance analysis (Current & future impact)
  • FIG. 15 Region wise adverse clinical trials outcomes, 2013
  • FIG. 16 Penetration & growth prospect mapping for technology, 2016
  • FIG. 17 Company market share analysis, 2016
  • FIG. 18 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 19 Porter's Five Forces Analysis
  • FIG. 20 Biotechnology market: Application outlook key takeaways
  • FIG. 21 Global biotechnology market: Application movement analysis
  • FIG. 22 Percentage of class-wise biopharmaceuticals offered by company
  • FIG. 23 Global health biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 24 Global food & agriculture biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 25 Global natural resources & environment market, 2014 - 2025 (USD Billion)
  • FIG. 26 Global industrial processing market, 2014 - 2025 (USD Billion)
  • FIG. 27 Global bioinformatics market, 2014 - 2025 (USD Billion)
  • FIG. 28 Global other applications market, 2014 - 2025 (USD Billion)
  • FIG. 29 Biotechnology market: Technology outlook key takeaways
  • FIG. 30 Biotechnology market: Technology movement analysis
  • FIG. 31 Breakdown of nanomedicine products in Phase III by therapeutic areas
  • FIG. 32 Global nanobiotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 33 Global tissue engineering and regeneration market, 2014 - 2025 (USD Billion)
  • FIG. 34 Global DNA sequencing market, 2014 - 2025 (USD Billion)
  • FIG. 35 Global cell based assays market, 2014 - 2025 (USD Billion)
  • FIG. 36 Global fermentation market, 2014 - 2025 (USD Billion)
  • FIG. 37 Global PCR technology market, 2014 - 2025 (USD Billion)
  • FIG. 38 Global chromatography instruments market, 2014 - 2025 (USD Billion)
  • FIG. 39 Global other technologies market, 2014 - 2025 (USD Billion)
  • FIG. 40 Regional market place: Key takeaway
  • FIG. 41 Biotechnology regional outlook, 2016 & 2025
  • FIG. 42 North America biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 43 U.S. biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 44 Canada biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 45 Europe biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 46 Germany biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 47 UK biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 48 Asia Pacific biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 49 Japan biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 50 China biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 51 Latin America biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 52 Brazil biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 53 Middle East & Africa biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 54 South Africa biotechnology market, 2014 - 2025 (USD Billion)
  • FIG. 55 Participant categorization
Back to Top